Cooperativity between the 3' untranslated region microRNA binding sites is critical for the virulence of eastern equine encephalitis virus.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
10 2019
Historique:
received: 21 05 2019
accepted: 20 09 2019
revised: 30 12 2019
pubmed: 29 10 2019
medline: 6 2 2020
entrez: 29 10 2019
Statut: epublish

Résumé

Eastern equine encephalitis virus (EEEV), a mosquito-borne RNA virus, is one of the most acutely virulent viruses endemic to the Americas, causing between 30% and 70% mortality in symptomatic human cases. A major factor in the virulence of EEEV is the presence of four binding sites for the hematopoietic cell-specific microRNA, miR-142-3p, in the 3' untranslated region (3' UTR) of the virus. Three of the sites are "canonical" with all 7 seed sequence residues complimentary to miR-142-3p while one is "non-canonical" and has a seed sequence mismatch. Interaction of the EEEV genome with miR-142-3p limits virus replication in myeloid cells and suppresses the systemic innate immune response, greatly exacerbating EEEV neurovirulence. The presence of the miRNA binding sequences is also required for efficient EEEV replication in mosquitoes and, therefore, essential for transmission of the virus. In the current studies, we have examined the role of each binding site by point mutagenesis of the seed sequences in all combinations of sites followed by infection of mammalian myeloid cells, mosquito cells and mice. The resulting data indicate that both canonical and non-canonical sites contribute to cell infection and animal virulence, however, surprisingly, all sites are rapidly deleted from EEEV genomes shortly after infection of myeloid cells or mice. Finally, we show that the virulence of a related encephalitis virus, western equine encephalitis virus, is also dependent upon miR-142-3p binding sites.

Identifiants

pubmed: 31658290
doi: 10.1371/journal.ppat.1007867
pii: PPATHOGENS-D-19-00934
pmc: PMC6936876
doi:

Substances chimiques

3' Untranslated Regions 0
MicroRNAs 0
Mirn142 microRNA, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1007867

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI095436
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI111115
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI132909
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist

Références

Genome Biol. 2007;8(8):R166
pubmed: 17697356
N Engl J Med. 1997 Jun 26;336(26):1867-74
pubmed: 9197215
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):941-6
pubmed: 22215596
Science. 2005 Sep 2;309(5740):1577-81
pubmed: 16141076
J Virol. 2008 Nov;82(21):10634-46
pubmed: 18768986
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12117-22
pubmed: 22778433
PLoS Pathog. 2012 Jan;8(1):e1002465
pubmed: 22241991
Intervirology. 2013;56(3):195-200
pubmed: 23594713
Trends Mol Med. 2017 Jan;23(1):80-93
pubmed: 27989642
J Virol. 2008 May;82(10):4920-30
pubmed: 18353963
Exp Biol Med (Maywood). 2015 Dec;240(12):1630-9
pubmed: 26080461
Blood. 2013 Feb 7;121(6):1016-27
pubmed: 23212522
Virology. 2014 May;456-457:247-58
pubmed: 24889244
Proc Natl Acad Sci U S A. 1988 Aug;85(16):5997-6001
pubmed: 3413072
Genome Biol. 2003;5(1):R1
pubmed: 14709173
Nat Genet. 2005 May;37(5):495-500
pubmed: 15806104
Front Genet. 2013 Aug 14;4:153
pubmed: 23967013
Am J Trop Med Hyg. 2014 Oct;91(4):685-93
pubmed: 25070997
Sci Signal. 2015 Dec 08;8(406):ra126
pubmed: 26645583
Nucleic Acids Res. 2007;35(7):2333-42
pubmed: 17389647
Virology. 2009 Aug 1;390(2):338-47
pubmed: 19539968
Cell. 1979 Oct;18(2):375-90
pubmed: 227607
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9779-84
pubmed: 12902540
Mol Cell. 2014 Oct 2;56(1):104-15
pubmed: 25263593
J Biol Chem. 2015 Feb 27;290(9):5381-90
pubmed: 25568327
Infect Immun. 1979 Jun;24(3):642-6
pubmed: 468371
Nat Rev Immunol. 2011 Oct 10;11(11):762-74
pubmed: 21984070
Genome Res. 2009 Jan;19(1):92-105
pubmed: 18955434
PLoS Biol. 2004 Nov;2(11):e363
pubmed: 15502875
Virus Res. 2015 Aug 3;206:99-107
pubmed: 25630058
Mol Cell. 2007 Jul 6;27(1):91-105
pubmed: 17612493
J Virol. 2010 Sep;84(17):8849-60
pubmed: 20554777
Nature. 2010 Aug 12;466(7308):835-40
pubmed: 20703300
J Gen Virol. 2009 Aug;90(Pt 8):1848-58
pubmed: 19403754
J Virol. 2012 May;86(10):5647-59
pubmed: 22419812
J Virol. 2013 May;87(10):5645-56
pubmed: 23468506
PLoS Pathog. 2019 Feb 11;15(2):e1007584
pubmed: 30742691
J Virol. 2014 Feb;88(4):2035-46
pubmed: 24307590
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16026-31
pubmed: 21896745
Virology. 2016 Sep;496:147-165
pubmed: 27318152
Nat Biotechnol. 2013 Sep;31(9):844-847
pubmed: 23934176
J Immunol. 2017 May 15;198(10):3791-3800
pubmed: 28483987
Emerg Infect Dis. 2010 Dec;16(12):1869-74
pubmed: 21122215
Cell Host Microbe. 2016 Mar 9;19(3):409-23
pubmed: 26962949
PLoS Pathog. 2016 Jul 27;12(7):e1005786
pubmed: 27463517
Cell. 2015 Mar 12;160(6):1099-110
pubmed: 25768906
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
Nat Rev Genet. 2013 Jul;14(7):447-59
pubmed: 23732335
Elife. 2015 Aug 12;4:null
pubmed: 26267216
Science. 2005 Apr 22;308(5721):557-60
pubmed: 15845854
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
J Virol. 1997 Jan;71(1):613-23
pubmed: 8985391
Science. 2002 Sep 20;297(5589):2056-60
pubmed: 12154197
Nature. 2014 Feb 13;506(7487):245-8
pubmed: 24352241

Auteurs

Derek W Trobaugh (DW)

Center for Vaccine Research, Department of Immunology and Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA United States of America.

Chengqun Sun (C)

Center for Vaccine Research, Department of Immunology and Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA United States of America.

Nishank Bhalla (N)

Center for Vaccine Research, Department of Immunology and Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA United States of America.

Christina L Gardner (CL)

Center for Vaccine Research, Department of Immunology and Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA United States of America.

Matthew D Dunn (MD)

Center for Vaccine Research, Department of Immunology and Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA United States of America.

William B Klimstra (WB)

Center for Vaccine Research, Department of Immunology and Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA United States of America.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH